ICM
NEOG icon

Invenomic Capital Management’s Neogen NEOG Stock Holding History

Invenomic Capital Management’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-490,008
Closed -$2.34M – 171
2025
Q2 		$2.34M Buy
+490,008
New +$2.81M 0.13% 131

Other funds holding NEOG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invenomic Capital Management's NEOG Position: Q3 2025 in Review

Invenomic Capital Management sold out of Neogen (NEOG) in Q3 2025, closing a stake of 490,008 shares — an estimated $2.34M sold.

Invenomic Capital Management first reported a position in NEOG in Q2 2025 and held it in 1 quarter. The position peaked at $2.34M in Q2 2025. 299 funds tracked by Wall St. Rank hold NEOG as of Q3 2025.

  • Invenomic Capital Management reported no remaining Neogen position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 490,008 Neogen shares in Q3 2025, an estimated $2.34M.
  • Invenomic Capital Management first reported a position in Neogen in Q2 2025 and held it in 1 quarter.
  • Invenomic Capital Management's Neogen position peaked at $2.34M in Q2 2025.
  • 299 funds tracked by Wall St. Rank held Neogen as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.